Results

eNauka >  Results >  Interim Safety and Efficacy Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis who Received Diroximel Fumarate for Up to 2 Years
Title: Interim Safety and Efficacy Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis who Received Diroximel Fumarate for Up to 2 Years
Authors: Wray, Sibyl; Singer, Barry A.; Drulović, Jelena S. ; Chen, Hailu; Hanna, Jerome; Lyons, Jennifer; Bergh, Florian Then; Kapadia, Shivani; Negroski, Donald
Issue Date: 2021
Publication: Neurology (2021 AAN 73rd Annual Meeting - Virtual)
ISSN: 0028-3878 Neurology Search Idenfier
Publisher: Hagerstown, MD : Lippincott Williams & Wilkins
Type: Conference Paper
Collation: vol. 96 br. 15, Suppl str. 2228
WoS-ID: 000729283602031
URI: https://enauka.gov.rs/handle/123456789/823271
URL: https://www.neurology.org/doi/10.1212/WNL.96.15_supplement.2228
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

1
WEB OF SCIENCETM

Find the DOI


Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.